[BCG-non specific immunotherapy of Hodgkin's disease. Preliminary results from a controlled investigation].
D000293:Adolescent; D000328:Adult; D001500:BCG Vaccine / Q000627:therapeutic use*; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D006801:Humans; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D011344:Procarbazine / Q000627:therapeutic use; D012075:Remission, Spontaneous; D013156:Splenectomy; D013997:Time Factors
D001500:BCG Vaccine; D011344:Procarbazine; D003520:Cyclophosphamide; D008775:Methylprednisolone
Immunothérapie non spécifique de la maladie de Hodgkin par BCG. Résultats préliminaires d'un essai contrôlé